Imaging service provider RadNet's DeepHealth artificial intelligence (AI) subsidiary has garnered U.S. Food and Drug Administration (FDA) clearance for its Saige-Q AI-based mammography triage software.
Designed as a screening worklist prioritization tool, Saige-Q automatically identifies suspicious screening mammography exams that may need prioritized attention by radiologists, according to the vendor. It supports 2D and 3D mammography studies.
The FDA clearance is the first for DeepHealth.
